Cumberland Pharmaceuticals Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDCumberland Pharmaceuticals Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 95), indicating clear outperformance against the broad market. Earnings contraction of 375% provides fundamental context to the price action. Investors should exercise caution due to high volatility (98% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.74 | +1.56% | ABOVE |
| 50 SMA | $4.87 | +19.81% | ABOVE |
| 100 SMA | $4.20 | +38.68% | ABOVE |
| 150 SMA | $3.95 | +47.71% | ABOVE |
| 200 SMA | $3.74 | +55.84% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CPIX in an uptrend right now?
CPIX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CPIX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is CPIX overbought or oversold?
CPIX's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is CPIX outperforming the market?
CPIX has a Relative Strength (RS) Rating of 95 out of 99. Yes, CPIX is a market leader, outperforming 95% of all stocks over the past 12 months.
Where is CPIX in its 52-week range?
CPIX is trading at $5.83, which is 88% of its 52-week high ($6.61) and 84% above its 52-week low ($1.85).
How volatile is CPIX?
CPIX has a Beta of 0.64 and 52-week volatility of 98%. It's less volatile than the S&P 500 - generally more stable.